Company: BIAF
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001641172-25-013280
Chunk: 37

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 37
---
 assert, or that a court would not sustain, a position contrary to any of the conclusions set forth
below.

This discussion is limited to U.S. holders (except
to the extent such discussion explicitly addresses non-U.S. holders) that hold Common Stock as “capital assets” within the
meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address any tax consequences arising
under the tax on net investment income or the alternative minimum tax, nor does it address any tax consequences arising under the laws
of any state, local or non-U.S. jurisdiction, U.S. federal estate or gift tax laws, or any tax treaties. Furthermore, this discussion
does not address all aspects of U.S. federal income taxation that may be applicable to U.S. holders in light of their particular circumstances
or to U.S. holders that may be subject to special rules under U.S. federal income tax laws, including, without limitation:

| ● | a                                                        
 bank, insurance company, or other financial institution; |

| ● | a tax-exempt or a governmental organization; |

| ● | a real estate investment trust; |

| ● | an S corporation or other pass-through entity (or an investor in an S corporation or other pass-through 
 entity);                                                                                                |

| ● | a regulated investment company or a mutual fund; |

| ● | a dealer or broker in stocks and securities or currencies; |

| ● | a trader in securities that elects mark-to-market treatment; |

| ● | a holder of Common Stock that received such stock through the exercise of an employee option, pursuant 
 to a retirement plan or otherwise as compensation;                                                     |

| ● | a                                                                                              
 person who holds Common Stock as part of a straddle, appreciated financial position, synthetic 
 security, hedge, conversion transaction, or other integrated investment or risk reduction      
 transaction;                                                                                   |

| ● | a corporation that accumulates earnings to avoid U.S. federal income tax; |

| ● | a person whose functional currency is not the U.S. dollar; |

| ● | a U.S. holder who holds Common Stock through non-U.S. brokers or other non-U.S. intermediaries; |

| ● | a U.S. holder owning or treated as owning 5% or more of the Company’s Common Stock; |

| ● | a person subject to Section 451(b) of the Code; or |

| ● | a former citizen or long-term resident of the United States subject